JP2021534818A5 - - Google Patents
Info
- Publication number
- JP2021534818A5 JP2021534818A5 JP2021533393A JP2021533393A JP2021534818A5 JP 2021534818 A5 JP2021534818 A5 JP 2021534818A5 JP 2021533393 A JP2021533393 A JP 2021533393A JP 2021533393 A JP2021533393 A JP 2021533393A JP 2021534818 A5 JP2021534818 A5 JP 2021534818A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- approximately
- cell line
- sequence encoding
- viral vector
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862722784P | 2018-08-24 | 2018-08-24 | |
| US62/722,784 | 2018-08-24 | ||
| PCT/US2019/047800 WO2020041647A1 (en) | 2018-08-24 | 2019-08-23 | Vector production in serum free media |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021534818A JP2021534818A (ja) | 2021-12-16 |
| JP2021534818A5 true JP2021534818A5 (enExample) | 2022-08-29 |
| JP7470119B2 JP7470119B2 (ja) | 2024-04-17 |
Family
ID=67874545
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021533393A Active JP7470119B2 (ja) | 2018-08-24 | 2019-08-23 | 無血清培地におけるベクター産生 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20210238632A1 (enExample) |
| EP (1) | EP3841212A1 (enExample) |
| JP (1) | JP7470119B2 (enExample) |
| KR (2) | KR102944997B1 (enExample) |
| CN (1) | CN112639109A (enExample) |
| AU (1) | AU2019325609A1 (enExample) |
| CA (1) | CA3109924A1 (enExample) |
| SG (1) | SG11202101594WA (enExample) |
| WO (1) | WO2020041647A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113518825A (zh) * | 2018-12-23 | 2021-10-19 | 美国杰特贝林生物制品有限公司 | Wiskott-aldrich综合征的造血干细胞基因疗法 |
| KR20230017799A (ko) * | 2020-05-15 | 2023-02-06 | 아이벡스솔, 아이엔씨. | 세포 및 유전자 요법을 위한 안정한 바이러스 벡터 생산자 세포를 생산하기 위한 조성물 및 방법 |
| CN111808859B (zh) * | 2020-07-13 | 2022-09-13 | 中国科学院广州生物医药与健康研究院 | WAS基因的gRNA及其应用 |
| JP2024539033A (ja) * | 2021-10-19 | 2024-10-28 | アムジエン・インコーポレーテツド | 組換えレンチウイルス産生のための組成物及び方法 |
| CN114045265A (zh) * | 2021-11-17 | 2022-02-15 | 深圳知因细胞生物科技有限公司 | 一种慢病毒体外转染人造血干细胞的试剂和试剂盒 |
| CN114716530B (zh) * | 2022-05-05 | 2023-11-10 | 明长(上海)生物医药科技有限公司 | 一种蛋白液、制备方法及应用 |
| JP2025520432A (ja) * | 2022-06-15 | 2025-07-03 | シーエスエル・ベーリング・エルエルシー | エンベロープ型ウイルスを産生する方法 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6013516A (en) | 1995-10-06 | 2000-01-11 | The Salk Institute For Biological Studies | Vector and method of use for nucleic acid delivery to non-dividing cells |
| ES2291025T3 (es) | 1998-05-13 | 2008-02-16 | Genetix Pharmaceuticals Inc. | Celulas lentivirales de empaquetamiento. |
| US9043994B2 (en) | 2007-03-13 | 2015-06-02 | Massachusetts Institute Of Technology | Cre-lox based gene knockdown constructs and methods of use thereof |
| WO2012170431A2 (en) | 2011-06-06 | 2012-12-13 | Bluebird Bio, Inc. | Improved geneswitch systems |
| WO2014043131A1 (en) * | 2012-09-14 | 2014-03-20 | The Regents Of The University Of California | Lentiviral vector for stem cell gene therapy of sickle cell disease |
| CA3229275A1 (en) | 2013-12-09 | 2015-06-18 | Sangamo Biosciences, Inc. | Methods and compositions for genome engineering |
| US10072067B2 (en) | 2014-01-30 | 2018-09-11 | Children's Hospital Medical Center | Fetal hemoglobin for genetic correction of sickle cell disease |
| US10350245B2 (en) * | 2015-01-21 | 2019-07-16 | Fred Hutchinson Cancer Research Center | Point-of-care and/or portable platform for gene therapy |
| DK3294893T5 (da) * | 2015-05-13 | 2024-10-07 | Csl Behring Gene Therapy Inc | Bioproduktion af lentivirale vektorer |
| KR20180014051A (ko) | 2015-05-28 | 2018-02-07 | 코넬 유니버시티 | 혈관 부종 치료제로서의 아데노-관련 바이러스 매개 c1e1의 전달 |
| CN108463243B (zh) | 2015-11-19 | 2022-06-14 | 夏尔人类遗传性治疗公司 | 重组人c1酯酶抑制剂及其用途 |
| US11352631B2 (en) | 2015-12-18 | 2022-06-07 | Sangamo Therapeutics, Inc. | Targeted disruption of the T cell receptor |
| US20190241910A1 (en) | 2016-03-11 | 2019-08-08 | Bluebird Bio, Inc. | Genome edited immune effector cells |
| KR102014349B1 (ko) | 2016-08-17 | 2019-08-26 | 서울대학교 산학협력단 | Jak 억제제를 포함하는 면역반응 억제용 조성물 |
| MA46018A (fr) | 2016-08-19 | 2019-06-26 | Bluebird Bio Inc | Activateurs d'édition du génome |
| AU2018256412B2 (en) | 2017-04-21 | 2025-02-27 | Seattle Children's Hospital (dba Seattle Children's Research Institute) | Optimized lentiviral vector for XLA gene therapy |
| CA3070242A1 (en) * | 2017-07-18 | 2019-01-24 | Calimmune, Inc. | Compositions and methods for treating beta-hemoglobinopathies |
-
2019
- 2019-08-23 JP JP2021533393A patent/JP7470119B2/ja active Active
- 2019-08-23 KR KR1020217008500A patent/KR102944997B1/ko active Active
- 2019-08-23 EP EP19765391.8A patent/EP3841212A1/en active Pending
- 2019-08-23 WO PCT/US2019/047800 patent/WO2020041647A1/en not_active Ceased
- 2019-08-23 AU AU2019325609A patent/AU2019325609A1/en not_active Abandoned
- 2019-08-23 KR KR1020267009049A patent/KR20260046530A/ko active Pending
- 2019-08-23 SG SG11202101594WA patent/SG11202101594WA/en unknown
- 2019-08-23 CA CA3109924A patent/CA3109924A1/en not_active Abandoned
- 2019-08-23 CN CN201980055424.9A patent/CN112639109A/zh active Pending
-
2021
- 2021-02-17 US US17/177,239 patent/US20210238632A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023166400A5 (enExample) | ||
| US12410445B2 (en) | Vector system for expressing regulatory RNA | |
| CN102575248A (zh) | 用于抑制单或多靶基因的多顺反子shRNA表达盒 | |
| US20190203170A1 (en) | Avian Cells for Improved Virus Production | |
| López et al. | A single stem-loop structure in Tacaribe arenavirus intergenic region is essential for transcription termination but is not required for a correct initiation of transcription and replication | |
| JP2019528084A5 (enExample) | ||
| WO2023035372A1 (zh) | 一种有限自我复制mRNA分子系统、制备方法及应用 | |
| CN116948003A (zh) | Eif2b4敲除细胞系的构建及作为小rna病毒科病毒疫苗生产细胞系的应用 | |
| CN117535288A (zh) | 一种抑制毛囊干细胞增殖的lncRNA | |
| US20060171924A1 (en) | Bidirectional promoters for small RNA expression | |
| JP2023087682A5 (enExample) | ||
| CN106754922A (zh) | 调控自身增殖的轮状病毒编码的小rna分子 | |
| CN105039388A (zh) | 重组单链负义植物病毒侵染性克隆构建方法及质粒和病毒 | |
| CN110066802B (zh) | 具有提高出芽短梗霉代谢产物的启动子及其应用 | |
| CN111518812A (zh) | 一种编辑绵羊FGF5基因实现选择性剪接的sgRNA、成套核酸分子和应用 | |
| CN117126855A (zh) | 一种构建Igf2bp1基因敲除小鼠胚胎干细胞系的方法 | |
| WO1998050405A1 (en) | An infectious clone for human parainfluenza virus type 3 | |
| JPH0253491A (ja) | ベクター及びその利用方法 | |
| CN105132459A (zh) | 人类ptx3重组蛋白的制备方法及应用 | |
| CN111849983A (zh) | 一种sgRNA及其应用 | |
| CN102604938B (zh) | 可用于诱导肝细胞损伤的rna干扰靶点 | |
| CN119082108A (zh) | 一种基于仿效微小rna杂合体的小核酸药物制备方法 | |
| US20140212886A1 (en) | Shuttle vectors for corynebacterium and escherichia coli | |
| WO2023221938A1 (zh) | 蛋白包裹自复制rna及其制备方法 | |
| CN121065346A (zh) | tollip基因在鱼类抗病毒免疫调控中的应用 |